Merck’s new ‘not Ivermectin’ Covid-19 treatment, molnupiravir, costs $17.74 to produce – yet the company is charging the US government $712 for the treatment – a 40x markup, according to The Intercept, citing a report issued last week by the Harvard School of Public Health and King’s College Hospital in London…
Bill Gates and Neo-Feudalism: A Closer Look at Farmer Bill…
Bill Gates has quietly made himself the largest owner of farmland in the United States. For a man obsessed with monopoly control, the opportunity to also dominate food production must seem irresistible…
Ten Experts on a NIH Wuhan Virus Panel Have Ties to Companies Involved in Wuhan Virus Treatment…
Members of the National Institutes of Health’s COVID-19 Treatment Guidelines Panel have financial ties to a company behind clinical trials of a drug to treat coronavirus, as well as to another large pharmaceutical company involved with developing a COVID-19 vaccine…
Merck Cyberattack’s $1.3 Billion Question: Was It an Act of War?…
By the time Deb Dellapena arrived for work at Merck & Co.’s 90-acre campus north of Philadelphia, there was a handwritten sign on the door: The computers are down. It was worse than it seemed. Some employees who were already at their desks at Merck offices across the U.S. were greeted by an even more […]